# \[e-drug\] ARVs in pregnanacy for PMTCT (2)

**URL:** <https://talk.edrugplus.org/t/e-drug-arvs-in-pregnanacy-for-pmtct-2/21388>\
**Category:** e-drug\
**Created:** [January 15, 2005, 12:28pm UTC](https://talk.edrugplus.org/t/e-drug-arvs-in-pregnanacy-for-pmtct-2/21388 "2005-01-15T12:28:44Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Joseph\_Serutoke2](https://avatars.discourse-cdn.com/v4/letter/j/e99b99/32.png) [@Joseph\_Serutoke2](https://talk.edrugplus.org/u/Joseph_Serutoke2)\
**Post date:** [January 15, 2005, 12:28pm UTC](https://talk.edrugplus.org/t/e-drug-arvs-in-pregnanacy-for-pmtct-2/21388/1 "2005-01-15T12:28:44Z")

</div>

E-DRUG: ARVs in pregnanacy for PMTCT (2)  
-----------------------------------------

Dr Dharmaraj

There are options you may consider and these are contained in the latest  
WHO Guidelines on Care, Treatment and Support for Women Living with  
HIV/AIDS and their Children in Resource-Constrained Settings.

The guidelines also provide specific recommendations for the most  
frequently encountered clinical situations and you can access them at:

[http://www.who.int/hiv/pub/mtct/en/arvdrugswomenguidelinesfinal.pdf](http://www.who.int/hiv/pub/mtct/en/arvdrugswomenguidelinesfinal.pdf)

Hope this is of assistance.

Joseph Serutoke  
Essential Drugs & Medicines Policy  
WHO Country Office Uganda  
P.O. Box 24578  
Kampala  
UGANDA  
Tel: + 256 41 335500  
Fax: + 256 41 335569  
Email: serutokej@ug.afro.who.int